secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2022-04-27T23:59:59+00:00
Accession:  0001096906-22-000948
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

UTMD Q1 2022 revenue +12.4%, EPS +16.6%; operating margin expands to 36.7%
--------------------------------------------------------------------------

- Revenue $12.3M, up 12.4% YoY; domestic sales +18%, OUS +4% (constant currency +7%).
- Net income $3.53M (+16.9%); diluted EPS $0.96 vs $0.82 in Q1 2021.
- Gross margin contracted to 61.1% from 63.4% on higher raw material and freight costs.
- Cash and investments $65.9M at Mar 31, 2022, up from $61.0M at Dec 31, 2021.
- No regular dividend paid in Q1 2022; special $2.00/share dividend was paid in Dec 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/0001096906-22-000948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/utmd-20220426.htm
  HTML page:      https://secwatch.observer/filing/0001096906-22-000948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer